Blog
Navigating the Formation Values Interview
The Formation Values Interview (FVI) is a distinctive component of the hiring process at Formation Bio, focused on evaluating candidates' alignment with our core values.
As we advance on our journey toward building the pharma company of the future, TrialSpark is now officially Formation Bio.
Pay Transparency at Formation Bio
We disclose salary ranges for all open roles at Formation Bio. Learn more about our compensation philosophy.
There are several thousand known human diseases, yet we only have FDA-approved treatments for about 500 of them. Patients are desperately waiting for more. We are building the pharma company of the future designed to bring new treatments to patients faster than ever before.
Select News Highlights
Partnership with major pharmaceutical company
Formation Bio (formerly known as TrialSpark) announces partnership with major pharmaceutical company to jointly acquire and develop clinical-stage novel therapies.
Licensing of potential osteoarthritis treatment
Formation Bio (formerly known as TrialSpark) licenses sprifermin, an investigational first-in-class disease modifying treatment for osteoarthritis, from Merck KGaA, Darmstadt, Germany and announces formation of High Line Bio.
Licensing of multiple immunodermatology assets
Formation Bio (formerly known as TrialSpark) announces acquisition of a clinical-stage immunodermatology portfolio and formation of Libertas Bio.